Last updated on April 21, 2014 at 1:20 EDT

Elsevier Announces the Launch of a New Journal: Wound Medicine

March 20, 2013

MUNICH, March 20, 2013 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, is pleased to announce the launch of Wound
Medicine [http://www.elsevier.com/journals/wound-medicine/2213-9095 ] – The International
Wound Journal for Clinical and Health Economics Research and Applications.

Published in print and online four times a year Wound Medicine is devoted to the
clinical, scientific and health economics aspects in the prevention, management and
reimbursement in wound care. The journal publishes original research papers and review
articles. In addition, the journal will feature standards and guidelines, commentaries,
health economic analyses and selected conference papers that meet the information need of
wound care specialists and service providers.

Thomas Wild and Thomas Eberlein, both from the Wound Academy in Hamburg and University
Medical Center Hamburg-Eppendorf, founded the journal. Together with a prestigious
international editorial team they aim to cover themes central to the journal such as:
tissue repair and wound healing, diabetic foot syndrome, clinical trials and outcomes,
health care and economics and service delivery. Their vision for Wound Medicine is to
advance the translation of science into clinical practice and application, to improve
outcomes and the patient experience.

“We are convinced that Wound Medicine will facilitate the development of standards and
enhance guidelines benefitting health care professionals in and beyond Europe by putting
emphasis on health improvement and economic benefits,” said Thomas Wild, “The journal has
been launched to provide a home for translational wound research, and we welcome
submissions from all affiliated clinical fields.”

“We are excited about the launch of Wound Medicine which will cover the rapidly
developing area of wound care, a subject of ever increasing importance,” added Helen
Habernickel, Publishing Editor at Elsevier. “Our aging and diabetes prone population is at
an increased risk of developing chronic wounds while normal wound healing decreases with
age. This journal will provide a publication platform for the advances made in wound

For more information or to submit an article, go to:


# # #

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], ClinicalKey
[http://www.clinicalkey.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading provider of professional information
solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Helen Habernickel
        Elsevier GmbH
        +49 30 644920374

SOURCE Elsevier

Source: PR Newswire